EPISODE · Nov 12, 2024 · 2H 32M
Escaping the USA For Medical Freedom - Deddrick Perry - ECS EP44
from The Ed Clay Show · host Ed Clay
Deddrick Perry, co-founder of CPI Stem Cells and serial entrepreneur/investor joins Ed for episode 44 of the podcast. In this episode Ed and Deddrick discuss CPI & The TAM Center's unique patient-centered approach, highlighting how it improves outcomes and creates a healing environment that mainstream healthcare often overlooks. Deddrick shares insights on the importance of staying open-minded and rejecting conventional limits, explaining how this mindset drives his work in healthcare and beyond.Together, Ed and Deddrick examine the challenges in the healthcare industry, from the resistance to innovative treatments like immunotherapy to the struggles of balancing patient care. They reflect on the power of addressing victimhood and fostering accountability, discussing how these principles shape Deddrick’s approach to both patient relationships and broader business ventures. This episode is packed with powerful insights on mindset, healthcare transformation, and what it takes to truly disrupt an industry for the better.Enjoy EP44 of ECS with CPI Stem Cells Co-Founder Deddrick Perry!Show Sponsors:https://www.beatdownbbq.com/https://healthquest365.com/https://www.edclayshow.com/ #cpistemcells #entrepreneurship #healthcare
What this episode covers
Deddrick Perry, co-founder of CPI Stem Cells and serial entrepreneur/investor joins Ed for episode 44 of the podcast. In this episode Ed and Deddrick discuss CPI & The TAM Center's unique patient-centered approach, highlighting how it improves outcomes and creates a healing environment that mainstream healthcare often overlooks. Deddrick shares insights on the importance of staying open-minded and rejecting conventional limits, explaining how this mindset drives his work in healthcare and...
NOW PLAYING
Escaping the USA For Medical Freedom - Deddrick Perry - ECS EP44
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m